BioNTech sees UK trials on cancer vaccines starting this year

Clinical trials for BioNTech's cancer vaccines are expected to begin this year in the United Kingdom, marking an important step towards their possible sale on the open market, according to the German company's top executive, Ugur Sahin, in the...

Sun Pharma acquires minority stakes in two healthcare firms for Rs 180 crore

Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies, has announced the acquisition of a 26.09% stake in digital health startups Agatsa Software Pvt. Ltd. and Remidio Innovative Solutions Pvt. Ltd. The move is part...

AstraZeneca gets CDSCO approval for drug to treat biliary tract cancer

AstraZeneca India announced that it has received approval from the country's drug regulator to market a drug to treat biliary tract cancer (BTC). Durvalumab has been approved by the Central Drugs Standard Control Organisation (CDSCO),...

Lupin's Nagpur facility receives EIR from US FDA

Lupin Limited (Lupin) announced that the United States Food and Drug Administration (US FDA) has approved the Establishment Inspection Report (EIR) for its new injectable facility in Nagpur...

PureTech Health to develop oral allopregnanolone to treat anxiety disorders and postpartum depression

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, announced that it will advance LYT-300 (oral allopregnanolone), a clinical therapeutic candidate in development as...

Aster Pharmacy collaborates with Dr. Reddy's to market its high-quality medicines in UAE and GCC

Aster Pharmacy, the retail arm of Aster DM Healthcare and a leading pharmacy chain in the GCC, and Dr. Reddy's laboratories India Ltd, a global pharmaceutical firm headquartered in Hyderabad, India, have signed a memorandum of understanding to...

Moderna's non-vaccine mRNA therapeutic set to generate $278 million in 2028

GlobalData, a data analytics firm, estimated that Moderna's mRNA-3927 is set to generate $278 million in 2028. Moderna recently confirmed that its Phase I/II study of candidate mRNA-3927 is moving forward. It also revealed that data from mRNA-3927...

MSD pharma likely to participate when govt issues tender for vaccine against cervical cancer

MSD Pharmaceuticals is likely to participate in a global tender that the Union Health Ministry is likely to float in April to procure HPV vaccine against cervical cancer for immunisation of girls aged 9 to 14. MSD Pharmaceuticals Private Limited...

Aurobindo Pharma gets VAI classification from USFDA for Telangana plant

Aurobindo Pharma said it has received Voluntary Action Indicated (VAI) from the US health regulator for its Telangana-based manufacturing plant. As per the information available on the United States Food and Drug Administration (USFDA) website,...

Torrent Pharma enters the OTC market with a calcium supplement

Torrent Pharmaceuticals said it has forayed into the over-the-counter segment in the country with Shelcal 500, a calcium supplement brand. With its composition of 500mg Calcium and 250 IU of Vitamin D3, Shelcal 500 helps optimise calcium...

© 2025 India Pharma Outlook. All Rights Reserved.